Celularity Inc. Increase (Decrease) in Prepaid Expense
Celularity Inc. (CELU) reported Increase (Decrease) in Prepaid Expense of -$26.21 thousand for the 9-month period ending 2020-09-30, per its 10-Q filed 2020-11-16.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpense · last filed 2020-11-16
- Celularity Inc. increase (decrease) in prepaid expense for the quarter ending 2020-09-30 was -$32.31K.
- Celularity Inc. increase (decrease) in prepaid expense for the quarter ending 2020-06-30 was -$20.73K.
- Celularity Inc. increase (decrease) in prepaid expense for the quarter ending 2020-03-31 was $26.83K.
- Celularity Inc. increase (decrease) in prepaid expense for the quarter ending 2019-12-31 was -$35.76K.
- Celularity Inc. increase (decrease) in prepaid expense for fiscal 2019 was $92.15K.
| Period end | Increase (Decrease) in Prepaid Expense 3 month | Increase (Decrease) in Prepaid Expense 6 month | Increase (Decrease) in Prepaid Expense 9 month | Increase (Decrease) in Prepaid Expense 12 month |
|---|---|---|---|---|
| 2020-09-30 | -$32.31K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | -$53.05K derived: sum of 2 quarters · filed 2020-11-16 | -$26.21K 10-Q · filed 2020-11-16 | -$61.98K derived: sum of 4 quarters · filed 2020-11-16 |
| 2020-06-30 | -$20.73K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | $6.10K 10-Q · filed 2020-08-13 | -$29.66K derived: sum of 3 quarters · filed 2020-08-13 | -$36.69K derived: sum of 4 quarters · filed 2020-11-16 |
| 2020-03-31 | $26.83K 10-Q · filed 2020-05-15 | -$8.93K derived: sum of 2 quarters · filed 2020-05-15 | -$15.96K derived: sum of 3 quarters · filed 2020-11-16 | |
| 2019-12-31 | -$35.76K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-24 | -$42.79K derived: sum of 2 quarters · filed 2020-11-16 | $92.15K 10-K · filed 2020-03-24 | |
| 2019-09-30 | -$7.03K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $127.91K 10-Q · filed 2020-11-16 | ||
| 2019-06-30 | $134.94K 10-Q · filed 2020-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |